The U.N. Security Council called for accelerated availability of coronavirus vaccines for Africa on Wednesday, expressing concern that the continent has received only about 2% of […]
A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs […]
The glutaminase (GLS1) inhibitor IACS-6274, discovered and developed by The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery division, appears to be well-tolerated with successful […]